1. Defining EGFR amplification status for clinical trial inclusion

   French, P. J., Eoli, M., Sepulveda, J. M., de Heer, I., Kros, J. M., Walenkamp, A., Frenel, J-S., Franceschi, E., Clement, P. M., Weller, M., Ansell, P., Looman, J., Bain, E., Morfouace, M., Gorlia, T. & van den Bent, M., Oct-2019, In : Neuro-Oncology. 21, 10, p. 1263-1272 10 p.

   Research output: Contribution to journal › Article › Academic › peer-review

2. Serotonin and Dopamine Receptor Expression in Solid Tumours Including Rare Cancers

   Peters, M. A. M., Meijer, C., Fehrmann, R. S. N., Walenkamp, A. M. E., Kema, I. P., de Vries, E. G. E., Hollema, H. & Oosting, S. F., 2-Sep-2019, In : Pathology & oncology research. 9 p.

   Research output: Contribution to journal › Article › Academic › peer-review

3. Use of selective serotonin reuptake inhibitors is associated with very low plasma free serotonin concentrations in humans

   Peters, M. A. M., van Faassen, M., de Jong, W. H. A., Bouma, G., Meijer, C., Walenkamp, A. M. E., de Vries, E. G. E., Oosting, S. F., Ruhé, H. G. & Kema, I., 18-Sep-2019, In : Annals of Clinical Biochemistry. 5 p.

   Research output: Contribution to journal › Article › Academic › peer-review

4. Quantitative Profiling of Platelet-Rich Plasma Indole Markers by Direct-Matrix Derivatization Combined with LC-MS/MS in Patients with Neuroendocrine Tumors

   van Faassen, M., Bouma, G., de Hosson, L. D., Peters, M. A. M., Kats-Ugurlu, G., de Vries, E. G. E., Walenkamp, A. M. E. & Kema, I. P., 24-Sep-2019, In : Clinical Chemistry. 9 p.

   Research output: Contribution to journal › Article › Academic › peer-review

5. Predictive value of the high-risk histopathological criteria in appendiceal neuroendocrine tumours and their correlation with lymph node status in additional right hemicolectomy

   Loveikyte, R., van Etten, B., Hemmer, P., Walenkamp, A. & Kats-Ugurlu, G., Sep-2019, In : Virchows Archiv. 475, p. S204 1 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

View all (90) »